Skip to content

Efficacy of Cognitive Bias Modification in Residential Treatment for Addiction

Efficacy of Cognitive Bias Modification in Residential Treatment for Addiction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03000699
Enrollment
88
Registered
2016-12-22
Start date
2017-03-01
Completion date
2018-12-31
Last updated
2019-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Dependence

Keywords

cognitive bias modification, interpretation bias, suicidal ideation, depression

Brief summary

The purpose of this study is to determine whether computer bias modification for interpretation bias (CBM-I) is effective in the reduction of suicidal ideation in substance use disorders.

Detailed description

Eighty-eight adult inpatients completing residential treatment in the Addictions Services at the Centre for Addiction and Mental Health (CAMH) will be randomized to receive CBM-I daily for one week, adjunct to the residential psychosocial treatment or to an assessment-only control condition. Participants will complete clinical measures consisting of interviews and questionnaires measuring suicidal ideation, hopelessness, depression, negative affect, and interpretation biases before, during and after treatment.

Interventions

Training paragraphs describe scenarios designed to be ambiguous at the outset and to resolve in a positive direction, with the intention of establishing a learning contingency between the ambiguity at the beginning of the scenario and the positive resolution that becomes clear towards the end of the statement.

Sponsors

American Foundation for Suicide Prevention
CollaboratorOTHER
Centre for Addiction and Mental Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Exhibit moderate suicide risk or greater * Be enrolled in the Addictions Services inpatient program * Fluent in reading English * Capacity to give informed consent

Exclusion criteria

* A lifetime diagnosis of a psychotic or bipolar disorder * Significant neurological disorder or psychical illness likely to interfere with participation * Psychotropic medication changes within the past two weeks

Design outcomes

Primary

MeasureTime frameDescription
Columbia-Suicide Severity Rating Scale, Screen Version (C-SSRS)Seven daysThis scale quantifies the severity of suicidal ideation and behaviour.

Secondary

MeasureTime frameDescription
Beck Hopelessness Scale (BHS)Seven daysThis questionnaire assesses thoughts and emotions associated with the future.
Beck Depression Inventory II (BDI-II)Seven daysThis questionnaire assesses severity of depressive symptoms and cognitions.
Positive and Negative Affect Schedule (PANAS)Seven daysThis questionnaire assesses current positive and negative mood
Scrambled Sentences TestsSeven daysThis computer test will be used as an implicit measure of negative interpretation bias.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026